Biotesserae Camunity
company
About
Biotesserae Camunity develops a nanobody-based platform designed for canine cancer treatments.
Details
- Last Funding Type
- Pre-seed
- Last Funding Money Raised
- $100K
- Industries
- Biotechnology,Health Care,Medical
- Founded date
- Oct 25, 2016
- Operating Status
- Active
Biotesserae Camunity is a nanobody-based platform for the production of a new class of therapeutics for canine cancer. The company was formed by Chris Cebra, chair of the Department of Clinical Sciences, and colleagues Shay Bracha, Dan Mourich, and Carl Ruby.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$100K
Biotesserae Camunity has raised a total of
$100K
in funding over 2 rounds. Their latest funding was raised on
Jan 6, 2022 from a Pre-seed round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 6, 2022 | Pre-seed | $100K | 1 |
EXPERT DOJO
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Biotesserae Camunity is funded by 1 investors.
EXPERT DOJO
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
EXPERT DOJO
|
Yes | Pre-seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
